La Marató 2018 supports UB research on cancer


The awards of La Marató 2018 were given in a ceremony on October 30.

The awards of La Marató 2018 were given in a ceremony on October 30.


This new edition of La Marató will create new tools for the prevention and diagnostic of cancer.

This new edition of La Marató will create new tools for the prevention and diagnostic of cancer.

La Marató de TV3 and Catalunya Ràdio in 2018, dedicated to research on cancer, assigned 15 million euros to fund 43 research projects of excellence to be carried out by 96 leading teams working on cancer research.

This series of resources –a record figure in all editions of la Marató- will create new tools for the prevention and diagnostic of cancer, and to design more efficient treatments to increase the quality and life expectancy of people with this pathology.

The 2018 edition received 192 projects, which were assessed by 149 international scientific experts on this issue regarding its quality, methodology and relevance.

The management of the evaluation was carried out by the Agency for Health and Assessment of Catalonia (AQuAS), from the Department of Health. Like in previous editions, the UB research is present once more in the awarded projects in this call.

Awarded projects in La Marató 2018 linked to the University of Barcelona:

Compostos bioactius dels aliments i el risc de càncer de pròstata. Bases científiques per futures recomanacions dietètiques

(Bioactive compounds in food and risk of prostate càncer. Scientific bases for future diet recommendations)

Raúl Zamora Ros, Faculty of Pharmacy and Food Sciences (University of Barcelona) and IDIBELL; Maria Cristina Andrés Lacueva, Faculty of Pharmacy and Food Sciences (University of Barcelona)

Funding: 300.000,00 €

Exclusió de les cèl·lules T durant l’evasió del sistema immunitari i la manca de resposta a la immunoteràpia del càncer: tipus cel·lulars, programes transcripcionals i biomecànica

(Exclusion of T cells during the immune system evasion and lack of response to cancer immunotherapy: cell types, transcriptional programs and biomechanics)

Xavier Trepat Guixer, Faculty of Medicine and Health Sciences (University of Barcelona) and Institute for Bioengineering of Catalonia (IBEC); Eduard Batlle Gómez (IRB Barcelona) and Holger Heyn (CNAG-CRG)

Funding: 400,000.00 €

Mecanismes de resistència a les teràpies moleculars dirigides en el limfoma de cèl·lules del mantell (RESTMCL)

(Resistance mechanisms to molecular therapies in the mantle cell lymphoma)

Sílvia M. Beà Bobet, Faculty of Medicine and Health Sciences (University of Barcelona) and IDIBAPS; Ramón García Sanz (Institute for Biomedical Research of Salamanca IBSAL – IESCYL Foundation)

Funding: 300,000.00 €

Identificació de noves dianes terapèutiques i biomarcadors de progressió del càncer de ronyó a través de models organoides i xenoempelts genèticament dissenyats per CRISPR

(Identification of new therapeutic targets and biomarkers for liver cancer progression through organoid and xenograft models genetically designed via CRISPR)

Laura Izquierdo Reyes, Faculty of Medicine and Health Sciences (University of Barcelona); Hospital Clínic and IDIBAPS; Oriol Casanovas Casanovas (ICO-IDIBELL); Núria Montserrat Pulido (IBEC)

Fiunding: 400,000.00 €

Abordatges endoscòpics mínimament invasius per a tumors cerebrals complexos. Disseny de nous models anatòmics i aplicació clínica

(Minimally invasive endoscopic approach for complex brain tumors. Design of new anatomic models and clinical application)

Joaquim Enseñat Nora, Faculty of Medicine and Health Sciences (University of Barcelona), Hospital Clínic and IDIBAPS; Alberto Prats Galino, Faculty of Medicine and Health Sciences (University of Barcelona); Luigi Maria Cavallo, University of Naples Frederic II (Italy).

Funding: 263,999.06 €

Immunoteràpia personalitzada per a càncer d’endometri

(Customized immunotherapy for endometrial cancer)

José Maria Piulats Rodríguez, Faculty of Medicine and Health Sciences (University of Barcelona), ICO and IDIBELL; Alena Gros Vidal (VHIO); Xavier Matias-Guiu Guia (Institute for Biomedical Research of Lleida – IRBLl); Ignacio Melero Bermejo (CIMA University of Navarra – FIMA Foundation for Applied Medical Research Navarra)

Funding: 396,684.28 €

Implementació de medicina personalitzada en melanoma maligne mitjançant intel·ligència artificial

(Implementation of personalized medicine in malignant melanoma through artificial intelligence)

Josep Malvehy Guilera, Faculty of Medicine and Health Sciences (University of Barcelona) and IDIBAPS; Verónica Vilaplana Besler (Barcelona School of Telecommunication Engineering – UPC)

Funding: 300,000.00 €

Estudi del rol dels factors de transcripció com a moduladors de la cromatina i conductors de les neoplàsies limfoides

(Study of the role of transcription factors as modulators of chromatin and drivers of lymphoid neoplasms)

José I. Martín Subero, Faculty of Medicine and Health Sciences (University of Barcelona) and IDIBAPS; Xabier Aguirre Ena (Center for Applied Medical Research – FIMA Foundation for Medical Research Navarra)

Funding: 296,250.00 €

La modulació de la glicèmia com a estratègia per millorar el benefici de la quimioradioteràpia i la immunoteràpia en càncer de pulmó de cèl·lula no petita

(Glycemia modulation as a strategy to improve the benefits of chemo-radiotherapy and immunotherapy in non-small cell lung cancer)

Cristina Muñoz Pinedo, Faculty of Medicine and Health Sciences (University of Barcelona) and IDIBELL; David Santamaría Velilla (University of Bordeaux, France)

Funding: 300,000.00 €

Estratègia terapèutica per a la leucèmia basada en la disrupció dels lisosomes

(Therapeutical strategy for leukaemia based on lysosome disruption)

Jordi Esteve Reyner, Faculty of Medicine and Health Sciences (University of Barcelona) and Clinic Institute of Hematological and Oncological Diseases – IDIBAPS; Ruth Muñoz Risueño (Josep Carreras)

Funding: 299,750.00 €

Optimització del maneig del càncer colorectal T1

(Optimization of T1 colorectal cancer management)

Maria Pellisé Urquiza, Faculty of Medicine and Health Sciences (University of Barcelona) and IDIBAPS; Ignasi Puig del Castillo (Hospital Sant Joan de Déu Manresa – Althaia Foundation)

Funding: 299,719.56 €

Identificació de mecanismes de resposta als inhibidors de CDK4/6 en càncer de mama receptor hormonal positiu

(Identification of response mechanisms to CDK4/6 inhibidors in hormone receptor-positive breast cancer)

Aleix Prat Aparicio, Faculty of Medicine and Health Sciences (University of Barcelona) and IDIBAPS; Eva González Suárez (IDIBELL); Roger Gomis Cabré, Faculty of Medicine and Health Sciences (University of Barcelona) and IRB Barcelona.

Funding: 400,000.00 €

Comprensió de la mecanotransducció mitjançada per YAP en càncer de pàncrees

(Mecano-transduction understanding through YAP in pancreas cancer)

Pere Roca-Cusachs Soulere, Faculty of Medicine and Health Sciences (University of Barcelona) and Institute for Bioengineering of Catalonia (IBEC); Miguel A. del Pozo Barriuso, National Center for Cardiovascular Research Carlos III

Funding: 300,000.00 €

Validació d’una firma molecular predictiva en tumors neuroendocrins

(Validation of predictive molecular sign in neuroendocrine tumors)

Ramon Salazar Soler, Faculty of Medicine and Health Sciences (University of Barcelona), Catalan Institute of Oncology and IDIBELL; Anguraj Sadanandam (the Institute of Cancer Research, United Kingdom)

Fiunding: 300,890.00 €

Funded projects by La Marató 2018

/Public Release. View in full here.